[Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease]
Related Experiment Video
Updated: Oct 9, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
1Academisch Ziekenhuis Vrije Universiteit, afd. Algemene Inwendige Geneeskunde, De Boelelaan 1117, 1081 HV Amsterdam. cda.stehouwer@azvu.nl
Insights
Postmenopausal hormone replacement therapy
Area of Science:
- Cardiovascular Science
- Endocrinology
- Women's Health
Background:
- Atherothrombotic cardiovascular disease is a major cause of mortality in postmenopausal women.
- The cardiovascular effects of postmenopausal hormone replacement therapy (HRT) remain controversial.
- Observational studies suggest HRT reduces cardiovascular disease (CVD) risk by 35-50% and improves lipid profiles.
Discussion:
- Recent randomized trials contradict observational findings, showing no significant CVD protection from HRT.
- Discrepancies may stem from lifestyle factor adjustments in observational studies and methodological flaws in trials.
- HRT's complex effects on atherothrombosis pathophysiology require further investigation.
Key Insights:
- Conflicting evidence exists regarding HRT's role in preventing postmenopausal cardiovascular disease.
- Methodological limitations in both observational and experimental studies may skew results.
- Isolating HRT's specific positive effects on atherothrombosis is crucial for future research.
Outlook:
- Further research is needed to clarify HRT's true impact on cardiovascular health in postmenopausal women.
- Future studies should focus on isolating beneficial HRT effects while mitigating potential risks.
- Understanding HRT's nuanced influence on atherothrombosis is key to optimizing women's cardiovascular care.
Abstract:
Atherothrombotic cardiovascular disease is a leading cause of death in women, especially in the postmenopause. It is controversial whether postmenopausal hormone replacement therapy is protective with regard to cardiovascular disease. On the one hand, observational studies consistently show that the risk of cardiovascular disease is 35 to 50% lower among users of hormonal replacement than among non-users. In addition, hormonal replacement is associated with an improvement of the lipid profile and several other potentially beneficial effects. On the other hand, two recent placebo-controlled randomised trials did not find evidence in favour of cardiovascular protection by hormonal replacement. This discrepancy may be explained by insufficient adjustment for lifestyle factors in observational studies and insufficient consideration of methodological flaws in experimental studies, both of which lead to an overestimation of the protective effect of hormonal replacement. Hormonal replacement may affect the pathophysiology of atherothrombosis in several ways, both positive and negative. Progress in this field requires the isolation of the positive effects.
Related Concept Videos
Menopause
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation
Hormonal Regulation
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Cancer Prevention
Some...
